Literature DB >> 6878692

Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging head and neck cancer. Part II: pathology.

A A Mancuso, H R Harnsberger, A S Muraki, M H Stevens.   

Abstract

Forty-one patients were examined (39 prospectively and 2 retrospectively) with computed tomography (CT) to determine its value in staging cervical and retropharyngeal nodal metastases. Precise surgical confirmation of CT findings was available in 25 patients. CT correctly increased the stage of the disease in six necks, and showed extranodal extent more precisely than the clinical examination in six others. The clinical evaluation proved superior to CT at predicting the extent of extranodal disease in two patients. Both CT and the clinical examination failed to detect microscopic tumor in normal-size nodes in two patients and falsely predicted tumor in enlarged nodes in one. CT offers information important for management and prognosis that is not available from the clinical examination in patients who have already been treated for cancer of the neck, and in patients with extranodal spread or retropharyngeal adenopathy. In the untreated neck CT will increase the stage of the disease from N0 to N1 about 5% of the time. Simple criteria for integrating CT into current clinical-diagnostic staging systems based on this and other experience are presented.

Entities:  

Mesh:

Year:  1983        PMID: 6878692     DOI: 10.1148/radiology.148.3.6878692

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  28 in total

1.  Contribution of doppler sonography blood flow information to the diagnosis of metastatic cervical nodes in patients with head and neck cancer: assessment in relation to anatomic levels of the neck.

Authors:  K Yonetsu; M Sumi; M Izumi; M Ohki; S Eida; T Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 2.  Management of cervical lymph nodes in patients with head and neck cancer.

Authors:  G B Snow; P Patel; C R Leemans; R Tiwari
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

3.  Computed tomography of the cranio-cervical lymphatic system: anatomical and functional considerations.

Authors:  J R Jinkins
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

Review 4.  Radiologic imaging modalities, including magnetic resonance, for evaluating lymph nodes.

Authors:  G C Dooms; H Hricak
Journal:  West J Med       Date:  1986-01

Review 5.  Diagnosis and treatment of the N0 neck in carcinomas of the upper aerodigestive tract: current status of diagnostic procedures.

Authors:  M Lenz; B Kersting-Sommerhoff; M Gross
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 6.  Methods of investigating metastatic lymph nodes in head and neck cancer.

Authors:  Bogdan Popescu; Patricia Ene; Serban Vifor Gabriel Bertesteanu; Razvan Ene; Catalin Cirstoiu; Cristian Radu Popescu
Journal:  Maedica (Buchar)       Date:  2013-09

7.  Prognostic value of tumor volume in nasopharyngeal carcinoma.

Authors:  Jeong-Hyun Kim; Joon-Kyoo Lee
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

8.  PET-CT staging of the neck in cancers of the oropharynx: patterns of regional and retropharyngeal nodal metastasis.

Authors:  Marcie Tauzin; Amy Rabalais; Joseph L Hagan; Charles G Wood; Robert L Ferris; Rohan R Walvekar
Journal:  World J Surg Oncol       Date:  2010-08-16       Impact factor: 2.754

Review 9.  Retropharyngeal and prevertebral spaces: anatomic imaging and diagnosis.

Authors:  J Matthew Debnam; Nandita Guha-Thakurta
Journal:  Otolaryngol Clin North Am       Date:  2012-12       Impact factor: 3.346

10.  [Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].

Authors:  A N Rahn; R P Baum; I A Adamietz; S Adams; S Sengupta; S Mose; S B Bormeth; G Hör; H D Böttcher
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.